Evidence map›Paper›PMID 39281582›Full record

ReviewHeliyon2024

AI in interventional cardiology: Innovations and challenges.

Dmitrii Khelimskii, Aram Badoyan, Oleg Krymcov, Aleksey Baranov, Serezha Manukian, Mikhail Lazarev

Abstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Artificial Intelligence in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dmitrii KhelimskiiMeshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
Aram BadoyanMeshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
Oleg KrymcovMeshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
Aleksey BaranovMeshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
Serezha ManukianMeshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
Mikhail LazarevHSE University, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) permeates all areas of our lives. Even now, we all use AI algorithms in our daily activities, and medicine is no exception. The potential of AI technology is hard to overestimate; AI has already proven its effectiveness in many fields of science and technology. A vast number of methods have been proposed and are being implemented in various areas of medicine, including interventional cardiology. A hallmark of this discipline is the extensive use of visualization techniques not only for diagnosis but also for the treatment of patients with coronary heart disease. The implementation of instrumental AI will reduce costs, in a broad sense. In this article, we provide an overview of AI research in interventional cardiology, practical applications, as well as the problems hindering the widespread use of neural network technologies in interventional cardiology.

Identifiers

PMID39281582
PMCPMC11402142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.